PD 0332991, a selective cyclin D kinase 4/6 inhibitor, sensitizes lung cancer cells to treatment with epidermal growth factor receptor tyrosine kinase inhibitors.
about
Therapeutic Challenge With a CDK 4/6 Inhibitor Induces an RB-dependent SMAC Mediated Apoptotic Response in Non-Small Cell Lung Cancer.Abemaciclib, a Selective CDK4/6 Inhibitor Enhances the Radiosensitivity of Non-Small Cell Lung Cancer in vitro and in vivo.[Aberrant Expression of Rb and pRb-780, pRb-795 in Lung Adenocarcinoma Patients with EGFR Mutations and Their Clinical Significance].[Role of PD 0332991 on the Proliferation and Apoptosis of Vascular Endothelial Cells].HOTAIR, a long noncoding RNA, is a marker of abnormal cell cycle regulation in lung cancer
P2860
PD 0332991, a selective cyclin D kinase 4/6 inhibitor, sensitizes lung cancer cells to treatment with epidermal growth factor receptor tyrosine kinase inhibitors.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
PD 0332991, a selective cyclin ...... or tyrosine kinase inhibitors.
@en
PD 0332991, a selective cyclin ...... or tyrosine kinase inhibitors.
@nl
type
label
PD 0332991, a selective cyclin ...... or tyrosine kinase inhibitors.
@en
PD 0332991, a selective cyclin ...... or tyrosine kinase inhibitors.
@nl
prefLabel
PD 0332991, a selective cyclin ...... or tyrosine kinase inhibitors.
@en
PD 0332991, a selective cyclin ...... or tyrosine kinase inhibitors.
@nl
P2093
P2860
P356
P1433
P1476
PD 0332991, a selective cyclin ...... tor tyrosine kinase inhibitors
@en
P2093
Hongbing Zhang
Hongyu Liu
Minghui Liu
Yongwen Li
P2860
P304
84951-84964
P356
10.18632/ONCOTARGET.13069
P407
P50
P577
2016-12-01T00:00:00Z